Where NeoGenomics Stands With Analysts
Portfolio Pulse from Benzinga Insights
NeoGenomics (NASDAQ:NEO) has received mixed analyst ratings in the last quarter, with 2 bullish, 2 somewhat bullish, and 1 indifferent. The average price target is $18.6, representing an upside from the current price of $12.5. However, this average represents a 4.62% decrease from the previous average price target of $19.50.
October 16, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
NeoGenomics has received mixed analyst ratings, with an average price target of $18.6, indicating potential upside.
The mixed analyst ratings indicate uncertainty about the company's performance. However, the average price target is higher than the current price, suggesting potential upside. This could positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100